Abbott secures CE mark for first dual glucose-ketone monitoring systems
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
A one-shot gene-editing cholesterol therapy could soon be a reality
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Subscribe To Our Newsletter & Stay Updated